Terms: = Kidney tumors AND TOP2A, TOP2, TP2A AND Prognosis
6 results:
1. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
[TBL] [Abstract] [Full Text] [Related]
2. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis.
Wang X; Wang J; Lyu L; Gao X; Cai Y; Tang B
Sci Rep; 2022 Jul; 12(1):11161. PubMed ID: 35778520
[TBL] [Abstract] [Full Text] [Related]
3. Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.
Yin X; Wang Z; Wang J; Xu Y; Kong W; Zhang J
Oncoimmunology; 2021; 10(1):1933332. PubMed ID: 34262797
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating top2a.
Zhang C; Qu Y; Xiao H; Xiao W; Liu J; Gao Y; Li M; Liu J
Exp Cell Res; 2019 Nov; 384(1):111595. PubMed ID: 31505165
[TBL] [Abstract] [Full Text] [Related]
5. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
[TBL] [Abstract] [Full Text] [Related]
6. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
[TBL] [Abstract] [Full Text] [Related]